本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ProKidney Corp.

4.34
+0.610016.35%
盘后4.730.3900+8.99%19:59 EDT
成交量:2.11亿
成交额:11.47亿
市值:5.79亿
市盈率:-7.29
高:7.13
开:5.81
低:4.18
收:3.73
数据加载中...
2024/03/18

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/03/18

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

重要事件披露

Form 8-K - Current report
2024/02/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/26

重要事件披露

Form 8-K - Current report
2024/01/19

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/11/30

重要事件披露

Form 8-K - Current report
2023/11/28

SEC问询函

Form CORRESP - Correspondence
2023/11/20

重要事件披露

Form 8-K - Current report
2023/11/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/02

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/10/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]